Trv Gp Iv, LLC Magenta Therapeutics, Inc. Transaction History

Trv Gp Iv, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 05, 2021	SELL	$6.07 - $9.89 $7.59 Million - $12.4 Million	-1,250,000 Reduced 15.61%	6,758,204 $49.2 Million
Q4 2018 Jan 28, 2019	BUY	$5.57 - $11.65 $44.6 Million - $93.3 Million	8,008,204 New	8,008,204 $45.6 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Trv Gp Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Trv Gp Iv, LLC with notifications on news.